Sanofi perfumes/beauty products 1995 sales "slightly up" at $774.7 mil.
This article was originally published in The Rose Sheet
Executive Summary
SANOFI PERFUMES/BEAUTY PRODUCTS SALES "SLIGHTLY UP" AT $774.7 MIL. (FFr 3.9 bil) during 1995 on a comparable basis, Sanofi reported March 20. "Successful launches" and "efforts focused on major products" in the firm's beauty business helped offset lower sales in France in December due to public sector strikes and the "further intensification of selective distribution," Sanofi explained. Operating profit for the business grew 10% to $65.7 mil. U.S. dollar figures are based on a March 19, 1996 exchange rate of $1 = FFr 5.0345
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.